CJC-1295 no DAC dosage usually runs 100–200 mcg per injection, one to three times daily, often paired with ipamorelin. See timing, weekly totals, and safety.
CJC-1295 no DAC dosage typically falls between 100 mcg and 200 mcg per injection, taken one to three times per day. That works out to roughly 0.7 mg to 2 mg per week when the peptide is used on its own. Most community protocols pair it with ipamorelin at a matching 100–200 mcg per injection.
CJC-1295 without DAC is a research peptide that is not FDA-approved for human use, so every number below comes from published research and user-reported protocols, not an official prescribing guideline.
Why "No DAC" Changes the Dosing Schedule
CJC-1295 without DAC — also called Mod GRF (1-29) — is a growth hormone-releasing hormone (GHRH) analog. It is identical to the longer-acting version except for the drug affinity complex that the "DAC" name refers to.
Removing that complex shortens the half-life from about a week to roughly 30 minutes, which changes how the peptide is used:
- Faster clearance: the peptide leaves circulation within hours, not days.
- Pulsatile release: growth hormone spikes are short and mimic the body's natural overnight pulses.
- More frequent injections: once-weekly dosing does not fit this version's pharmacokinetics.
Anyone asking what does cjc 1295 no dac do is usually trying to work out whether the shorter half-life makes it weaker. Per microgram it is not weaker — it simply clears faster, which is why frequency and timing matter more than total milligrams per week.
CJC-1295 Without DAC Dosage Per Day
Reported daily ranges cluster into three bands:
- Low: 100 mcg once or twice daily, about 0.7–1.4 mg per week.
- Standard: 100–200 mcg two to three times daily, about 1.4–2 mg per week.
- Higher: 200–300 mcg per injection, usually capped at two injections per day.
Splitting the weekly amount into smaller, more frequent doses is the common approach because the short half-life limits how long each pulse lasts. A cjc-1295 no dac dosage chart usually lists these bands next to the DAC version so users can compare weekly totals at a glance.
Commonly Cited Dosages for CJC-1295 and Related Peptides
| Peptide | Typical dose per injection | Frequency | Approx. weekly total | Half-life |
|---|---|---|---|---|
| CJC-1295 no DAC (Mod GRF 1-29) | 100–200 mcg | 1–3 times daily | 0.7–2 mg | ~30 minutes |
| CJC-1295 with DAC | 1–2 mg | Once or twice weekly | 1–2 mg | ~6–8 days |
| Ipamorelin | 100–300 mcg | 1–3 times daily | 0.7–2.1 mg | ~2 hours |
| Sermorelin | 100–300 mcg | 1–3 times daily | 0.7–2.1 mg | ~10–20 minutes |
| CJC-1295 no DAC + ipamorelin | 100–200 mcg of each | 1–3 times daily | 0.7–1.4 mg of each | ~30 min / ~2 hr |
CJC-1295 and Ipamorelin Without DAC Dosage Together
The most widely repeated ipamorelin cjc-1295 no dac dosage is 100 mcg of each peptide per injection, two to three times daily. Some users scale up to 200 mcg of each, and a smaller group runs asymmetric ratios such as 100 mcg CJC-1295 with 200 mcg ipamorelin.
The rationale is receptor coverage: CJC-1295 acts on GHRH receptors while ipamorelin acts on ghrelin receptors, so stacking them can produce a larger growth hormone pulse than either peptide alone. Ipamorelin is also described as more selective, with less effect on cortisol and prolactin than older ghrelin mimetics.
Keep expectations realistic. Much of what circulates about cjc-1295 ipamorelin no dac reddit logs comes from personal trackers and bloodwork snapshots rather than controlled trials, and individual responses vary widely.
Timing: When to Inject CJC-1295 Without DAC
Because the peptide triggers a pulse that lasts only a short time, timing relative to meals and sleep matters more than it does with the DAC version.
- Before bed: 30–60 minutes after the last meal is the most common choice, since natural growth hormone output peaks during deep sleep.
- Morning, fasted: a second injection is often placed before breakfast.
- Post-workout: some protocols add a dose after training, though insulin from a post-workout meal may blunt the growth hormone response.
- Avoid: injecting within 30–60 minutes of a carbohydrate-heavy meal, which raises insulin and reduces growth hormone release.
Weekly totals stay the same no matter how the doses are distributed. A cjc-1295 without dac dosage per week of roughly 1.4 mg can be split into 100 mcg twice daily, 200 mcg once daily, or 100 mcg three times daily on some days.
Safety, Legal Status, and Sourcing
CJC-1295 without DAC is sold as a research chemical, and it is not FDA-approved for human use in the United States. There are no large human trials establishing safe long-term dosing, and no recognized maximum dose.
Side effects reported in user accounts include injection site irritation, flushing, headache, dizziness, increased appetite, and fluid retention. Because the peptide raises growth hormone, longer-term concerns include joint pain, carpal tunnel symptoms, and shifts in blood sugar or insulin sensitivity.
People with a history of cancer, diabetes, or pituitary disorders, and anyone who is pregnant or breastfeeding, should not use these peptides without medical supervision. Anyone using them at all should do so with a healthcare professional's oversight and periodic bloodwork.
If you decide to buy cjc-1295 no dac, third-party certificates of analysis, verified purity, and cold-chain shipping matter far more than a low price. Under US law the peptide is not approved for human consumption, so quality control rests entirely with the supplier.
How CJC-1295 Without DAC Compares With Other Options
cjc 1295 no dac vs sermorelin comparisons usually come down to half-life and pulse intensity. Sermorelin clears even faster — roughly 10 to 20 minutes — and is often described as producing a gentler, more physiologic pulse, while CJC-1295 without DAC delivers a longer, stronger signal per microgram.
Against CJC-1295 with DAC, the trade-off is convenience versus control. The DAC version needs only one or two injections per week, while the no-DAC version requires daily dosing but does not keep blood levels elevated around the clock.
Whichever protocol is discussed, the peptide remains an unapproved research compound. Dosing decisions belong with a qualified clinician who can review medical history, monitor labs, and adjust or stop use if side effects appear.
RELATED PEPTIDE TOPICIpamorelin peptide researchFrequently Asked Questions
What is the typical CJC-1295 no DAC dosage per day?
Most reported protocols use 100–200 mcg per injection, one to three times daily, for a weekly total of roughly 0.7–2 mg. The peptide's short half-life of about 30 minutes is the reason doses are split rather than taken once a week. CJC-1295 without DAC is not FDA-approved for human use.
How much CJC-1295 and ipamorelin without DAC do people take together?
The most common combination is 100 mcg of CJC-1295 no DAC plus 100 mcg of ipamorelin per injection, two to three times daily. Some users go up to 200 mcg of each, and a few run asymmetric ratios. These figures come from user reports, not clinical trials.
How often should CJC-1295 without DAC be injected?
Because the half-life is only about 30 minutes, injections are typically spaced one to three times per day, most often before bed and sometimes again in the morning. Weekly totals generally stay in the 0.7–2 mg range regardless of how the doses are divided.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.